Analysis for the mechanism of graft coronary arteriosclerosis

移植冠状动脉硬化的机制分析

基本信息

  • 批准号:
    06671342
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

We developed long-term acceptance of rat heart allografts induced by short-course treatment of FK506 in both MHC antigen mismatch and non-MHC,minor antigen mismatch combinations. Graft coronary arteriosclerosis (GCAS) was occurred in these long surviving grafts Definite GCAS change was clarified on day 40 after transplantation. In spite of FK506 treatment, in vitro cellular activities analyzed recipient spleen T cells were recognized in early phase of posttransplantation in both MHC and non-MHC mismatch combinations. Anti-donor antibodies were detected in some cases of MHC mismatch combination, but not in any cases of non-MHC mismatch combination throughout the observation time. These data suggest that anti-donor antibody is not essential for GCAS induction. We examined that whether continuous allostimulation was necessary for GCAS induction by retransplantation of allografts back into the original donor strain in this established GCAS model. We call this technique return transplantation. To ascertain the point at which the GCAS changes become irreversible, the grafted hearts were removed on day 3,5,7, or 9, and retransplanted into the donor strain rats to prevent further immunological stimulation. These retransplanted grafts were examined to evaluate the grade of GCAS on day 40. Retransplanted heart allografts back into the original donor strain did not prevent GCAS if the graft had resided in the first recipient for up to 5 days after first transplantation. In conclusion, return transplantation technique revealed that graft coronary arteriosclerosis was induced between 3 and 5 days posttransplantation and develop without subsequent allostimulation.
我们开发了长期接受大鼠心脏移植诱导短期治疗FK 506在MHC抗原错配和非MHC,次要抗原错配组合。移植物冠状动脉粥样硬化(GCAS)发生于移植后40天。尽管FK 506治疗,体外细胞活性分析受体脾T细胞在移植后早期在MHC和非MHC错配组合中被识别。在整个观察时间内,在某些MHC错配组合病例中检测到抗供体抗体,但在任何非MHC错配组合病例中均未检测到。这些数据表明,抗供体抗体不是GCAS诱导所必需的。我们研究了在这个建立的GCAS模型中,通过将同种异体移植物再次移植回原始供体品系来诱导GCAS是否需要持续的同种异体刺激。我们称这种技术为回植。为了确定GCAS变化变得不可逆的时间点,在第3、5、7或9天取出移植的心脏,并重新移植到供体品系大鼠中以防止进一步的免疫刺激。在第40天检查这些再次移植的移植物以评估GCAS的等级。如果移植物在首次移植后在第一个受体体内停留长达5天,则将心脏同种异体移植物重新移植回原始供体品系并不能预防GCAS。总之,回植技术显示移植物冠状动脉硬化是在移植后3 - 5天诱导的,并且在没有随后的同种异体刺激的情况下发展。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H. izutani, S. Miyagawa, R. Shirakura, G. Matsumiya, S. Nakata, Y. Shimazaki, H. Matsuda: "Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction" Transplantation. 60. 10
H. izutani、S. Miyakawa、R. Shirakura、G. Matsumiya、S. Nakata、Y. Shimazaki、H. Matsuda:“证据表明移植物冠状动脉硬化在移植后早期开始,并且在没有慢性免疫反应的情况下进展” 移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.izutani,R.Shirakura,et al.: "Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction" Transplantation. 60. 1073-1079 (1995)
H.izutani、R.Shirakura 等人:“有证据表明移植物冠状动脉硬化在移植后早期开始,并且在没有慢性免疫反应的情况下进展” 移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANIGUCHI Kazuhiro其他文献

TANIGUCHI Kazuhiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANIGUCHI Kazuhiro', 18)}}的其他基金

KOMEKAMI Switch: A Novel Wearable Input Device Using Movement of Temple
KOMEKAMI Switch:一种利用镜腿运动的新型可穿戴输入设备
  • 批准号:
    20700110
  • 财政年份:
    2008
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Myocardial beta-adrenoceptor Function after brain death
脑死亡后心肌β-肾上腺素受体功能
  • 批准号:
    02670606
  • 财政年份:
    1990
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection
慢性移植物抗宿主病和实体器官移植慢性排斥的调节性自然杀伤细胞治疗
  • 批准号:
    441672
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Operating Grants
The role of macrophages in chronic rejection after lung transplantation and regulatioon of macrophage activities by FROUNT inhibition
巨噬细胞在肺移植后慢性排斥反应中的作用及FROUNT抑制对巨噬细胞活性的调节
  • 批准号:
    21K08898
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of tissue resident memory T cells on chronic rejection after lung transplantation
组织驻留记忆T细胞对肺移植后慢性排斥反应的影响
  • 批准号:
    10646332
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Impact of tissue resident memory T cells on chronic rejection after lung transplantation
组织驻留记忆T细胞对肺移植后慢性排斥反应的影响
  • 批准号:
    10459217
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging
使用超极化 129Xe 成像预测肺移植受者慢性排斥反应的发生
  • 批准号:
    10192820
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Impact of tissue resident memory T cells on chronic rejection after lung transplantation
组织驻留记忆T细胞对肺移植后慢性排斥反应的影响
  • 批准号:
    10202733
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging
使用超极化 129Xe 成像预测肺移植受者慢性排斥反应的发生
  • 批准号:
    10407561
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
Development of selective immunosuppressive therapy preserving natural immunity for treating chronic rejection after lung transplantation
保留自然免疫力的选择性免疫抑制疗法的发展用于治疗肺移植后的慢性排斥反应
  • 批准号:
    18H02893
  • 财政年份:
    2018
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of an immunological monitoring system to predict chronic rejection in kidney transplant recipients.
开发免疫监测系统来预测肾移植受者的慢性排斥反应。
  • 批准号:
    18K09156
  • 财政年份:
    2018
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of an early diagnosis of chronic rejection after lung transplantation by micro pulmonary vascular measurement
微肺血管测量技术发展肺移植后慢性排斥反应的早期诊断
  • 批准号:
    18K15579
  • 财政年份:
    2018
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了